<DOC>
	<DOCNO>NCT00125255</DOCNO>
	<brief_summary>The pain associate medical procedure often under-treated child . Children often undergo painful procedure little anesthetic , even effective therapy available . Reasons provide available therapy child include concern adverse side effect well length time necessary provide adequate anesthesia . Recent guideline strongly advocate proactive treatment pain child , include pain associate medical procedure . S-Caine™ Peel ( lidocaine 7 % tetracaine 7 % cream ) eutectic formulation lidocaine tetracaine . The purpose study evaluate whether S-Caine Peel effective provide topical local dermal anesthesia prior vascular access procedure child 5 17 year age .</brief_summary>
	<brief_title>S-Caine™ Peel ( Skin Numbing Cream ) Treat Pain During Vascular Access Procedures Children</brief_title>
	<detailed_description>This randomize , double-blind , placebo-controlled , parallel study evaluate effectiveness S-Caine Peel provide local dermal anesthesia vascular access procedure child 5 17 year age . Patients randomize 1:1 receive either one application S-Caine Peel one application placebo 30 minute prior vascular access procedure . During screen visit , study fully explain patient 's legal guardian write informed consent obtain . Whenever possible , patient provide assent . The screen visit also include : evaluate eligibility criterion ; obtain medical history ( include skin type , demographic data , concomitant medication ) ; obtain brief physical examination urine pregnancy test ( female childbearing potential ) , negative patient enroll study ; provide patient education ass pain use Colored Analog Scale ( CAS ) . The screening visit could occur day procedure visit . Upon meet eligibility criterion complete screen visit , patient assign next available sequential patient number age group ( 5-11 year 12-17 year ) . Based upon randomized code , patient randomize receive either S Caine Peel placebo 30 minute schedule vascular access procedure . The study drug application site could either patient 's left right antecubital surface cover area 10 cm2 . A thin layer ( approximately 1 mm thickness dime ) study drug apply evenly across area treat 30 minute . Immediately follow removal study drug , study drug application site evaluate erythema , edema , blanch skin reaction . The vascular access procedure perform . Upon completion vascular access procedure , investigator 's evaluation procedural pain intensity assessment adequacy anesthesia provide study drug complete . Following assessment , patient assess procedural pain intensity use CAS . All pain evaluation complete first attempt gain vascular access . If first attempt unsuccessful attempt require , procedure stop pain assessment perform attempt vascular access make .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Patient 5 17 year age . Patient medical indication undergo venous vascular access procedure ( exclude peripherally insert central catheter [ PICC ] line ) antecubital surface . Patient pregnant breastfeeding . Patient participate clinical trial unapproved drug within previous 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>